Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S178-83. doi: 10.2337/dc09-S306.

Authors

Piero Marchetti¹, Roberto Lupi, Silvia Del Guerra, Marco Bugliani, Valentina D'Aleo, Margherita Occhipinti, Ugo Boggi, Lorella Marselli, Matilde Masini

Affiliation

¹ Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. marchant@immr.med.unipi.it

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Blood Glucose / metabolism*
Diabetes Mellitus, Type 2 / pathology
Diabetes Mellitus, Type 2 / physiopathology*
Diabetes Mellitus, Type 2 / therapy*
Disease Progression
Fatty Acids, Nonesterified / pharmacology
Glucose Intolerance / physiopathology
Homeostasis
Humans
Hyperglycemia / physiopathology
Hypoglycemic Agents / therapeutic use
Insulin / metabolism
Insulin Secretion
Insulin-Secreting Cells / drug effects
Insulin-Secreting Cells / metabolism
Insulin-Secreting Cells / pathology
Insulin-Secreting Cells / physiology*
Longitudinal Studies
Metformin / pharmacology

Substances

Blood Glucose
Fatty Acids, Nonesterified
Hypoglycemic Agents
Insulin
Metformin